Bradford D. Dahms
2021 - SELECTA BIOSCIENCES
In 2021, Bradford D. Dahms earned a total compensation of $868.1K as Chief Financial Officer at SELECTA BIOSCIENCES, a 10% decrease compared to previous year.
Compensation breakdown
| Option Awards | $526,588 |
|---|---|
| Salary | $183,206 |
| Stock Awards | $154,733 |
| Other | $3,526 |
| Total | $868,053 |
Dahms received $526.6K in option awards, accounting for 61% of the total pay in 2021.
Dahms also received $183.2K in salary, $154.7K in stock awards and $3.5K in other compensation.
Rankings
In 2021, Bradford D. Dahms' compensation ranked 9,234th out of 12,412 executives tracked by ExecPay. In other words, Dahms earned more than 25.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,234 out of 12,412 | 26th |
Division Manufacturing | 4,094 out of 5,498 | 26th |
Major group Chemicals And Allied Products | 1,805 out of 2,374 | 24th |
Industry group Drugs | 1,605 out of 2,095 | 23rd |
Industry Pharmaceutical Preparations | 1,189 out of 1,542 | 23rd |
Source: SEC filing on May 3, 2022.
Dahms' colleagues
We found six more compensation records of executives who worked with Bradford D. Dahms at SELECTA BIOSCIENCES in 2021.
2021
Carsten Brunn
SELECTA BIOSCIENCES
Chief Executive Officer
2021
Kevin Tan
SELECTA BIOSCIENCES
Chief Financial Officer
2021
Peter Traber
SELECTA BIOSCIENCES
Chief Medical Officer
2021
Takashi Kishimoto
SELECTA BIOSCIENCES
Chief Scientific Officer
2021
Lloyd Johnston
SELECTA BIOSCIENCES
Chief Operations Officer
2021
Ann Donohue
SELECTA BIOSCIENCES